U.S. study examines whether COVID-19 vaccines increase the risk of GBSU.S. Vaccine Adverse Event Reporting System used to determine risk of Guillain-Barré syndrome following use of three different COVID-19 vaccines Avoid walking or biking down busy streets: Traffic fumes may affect brain connectivity, new Canadian study showsBritish Columbia researchers use functional MRI to study diesel fumes and brain connectivity. The symptoms that stick around: Quebec researchers examine persistent symptoms following Omicron infection Study identifies risk factors and prevalence of ongoing symptoms after SARS-CoV-2 Omicron infection in adults. Why does the Alzheimer’s brain become insulin-resistant? We still don’t know what cell types and mechanisms are involved in the action—and loss of action—of insulin in the brain. Celine Dion says she has 'stiff person syndrome.' Here's what that means The name doesn't do justice to the pain and life-changing symptoms the syndrome causes. Drug slows Alzheimer's but can it make a real difference? Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work. Free migraine master classes offered to healthcare professionals Classes featuring experts on migraine science will be available around the world. Ubrogepant will be the first oral CGRP antagonist for acute migraine in Canada Health Canada approves Ubrelvy (ubrogepant) for treating acute migraine, with or without aura, in adults TNFα-inhibitor biologics for rheumatic disease linked to the development of MS Study examines risk of multiple sclerosis among users of antitumour necrosis factor alpha biologics in four Canadian provinces SickKids study uncovers 134 genes linked to autism The study, which was published in Cell, is the largest whole genome sequencing study for autism in the world. First Previous 17 18 19 20 21 Next Last
